Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
10/01/2003 | EP1348036A2 Protection against mycobacterial infections |
10/01/2003 | EP1348026A2 Fibrin binding moieties useful as imaging agents |
10/01/2003 | EP1348022A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
10/01/2003 | EP1348021A2 25206, a novel human short-chain dehydrogenase/reductase family member and uses thereof |
10/01/2003 | EP1347993A2 Superficial zone protein and methods of making and using same |
10/01/2003 | EP1347990A2 Peptide mit inhibierender aktivität zur produktion von stickstoffmonoxid |
10/01/2003 | EP1347989A1 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
10/01/2003 | EP1347953A2 Agents and methods for promoting bone growth |
10/01/2003 | EP1347783A1 Conjugates of integrin receptor antagonists and a cytostatic agent having specifically cleavable linking units |
10/01/2003 | EP1347774A2 Modulation of cell growth by inhibiting binding of kringle 2 domain of plasminogen |
10/01/2003 | EP1347773A2 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines |
10/01/2003 | EP1347772A2 Educated nk t cells and their uses in the treatment of immune-related disorders |
10/01/2003 | EP1347771A2 Methods of using imxp-888 and imxp-888 antagonists |
10/01/2003 | EP1347751A2 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
10/01/2003 | EP1204655B1 A crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy] phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
10/01/2003 | EP1100830B1 Heterominibodies |
10/01/2003 | EP1056467B1 Method for the treatment of diseases or disorders of the inner ear |
10/01/2003 | EP1019434B1 Inhibitors of metalloproteinases, their therapeutic use, and process for the production of the starting compound in their synthesis |
10/01/2003 | EP0999825B1 Ophthalmic compositions containing galactomannan polymers and borate |
10/01/2003 | EP0946589B1 Inhibitors of peptide binding to mhc class ii proteins |
10/01/2003 | EP0914043B1 Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
10/01/2003 | EP0912612B1 Simplified production of bispecific antibody fragments |
10/01/2003 | EP0891331B1 N-(2 oxoacetyl or sulphonyl)-pyrrolidine/piperidine-2-carboxylic acid derivatives with improved multi-drug resistance activity |
10/01/2003 | EP0863917B1 Targeted cytotoxic anthracycline analogs |
10/01/2003 | EP0783511B1 Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
10/01/2003 | EP0662087B1 Method for purifying retinal pigmented epithelium derived neurotrophic factor |
10/01/2003 | CN1446261A Modified cytokines for use in cancer therapy |
10/01/2003 | CN1446230A Peptide and peptide mimetic derivatives with integrin inhibitor preperties Ôàí" |
10/01/2003 | CN1446229A Somatostatin analogues |
10/01/2003 | CN1446228A 校正基因 Correction gene |
10/01/2003 | CN1446227A Novel fibroblast growth factor (FRF23) and method for use |
10/01/2003 | CN1446201A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
10/01/2003 | CN1446105A Medicinal compositions for angiogenic therapy |
10/01/2003 | CN1446104A Treatment of B cell malignancies using combination of B cell depleting antibody and immune modulating antibody related applications |
10/01/2003 | CN1446101A Combination product comprising melagatran and factor VLLa inhibitor |
10/01/2003 | CN1446100A Method for treating movement disorder |
10/01/2003 | CN1446099A Remedies for chronic hepatitis B |
10/01/2003 | CN1446098A Modulation of alpha-6 integrin-mediated responses |
10/01/2003 | CN1446096A Treatment of hepatitis C with thymosin, interferon and ribavirin |
10/01/2003 | CN1446084A Treatment of insulin resistance syndrome |
10/01/2003 | CN1446081A 神经毒素植入物 Neurotoxin implants |
10/01/2003 | CN1446077A Inhaleable spray dried 4-holix bundle protein powders having minimized aggregation |
10/01/2003 | CN1445366A New protein kinase specific to human cardiac muscle and its coded sequence |
10/01/2003 | CN1445365A Method for preparing algin lyase and its application |
10/01/2003 | CN1445364A Live scorpion enzyme and its preparing method |
10/01/2003 | CN1445240A Killer cell antibiosis polypeptide activated by lymphokine and its application |
10/01/2003 | CN1445239A Mutain of human stem cell growth fcator as well as its preparing method and medicine combination |
10/01/2003 | CN1445238A Conformation type peptide library based on insect alexins, its constitute method and application |
10/01/2003 | CN1445237A Anagonism peptide of tumor necrosis factor and its application |
10/01/2003 | CN1444993A Application of the recombination human interferon omega in preparing medicine for preventing and treating not typical model pneumonia |
10/01/2003 | CN1444992A Method and combination for treating tumors based on ERBB-3 |
10/01/2003 | CN1444991A Preparing method and usage of cardiotoxin |
10/01/2003 | CN1122719C Modified biological material |
10/01/2003 | CN1122718C Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
10/01/2003 | CN1122716C Extracorporeal ceel culture and transplantation kits |
10/01/2003 | CN1122534C Method for reducing side effects of drug |
10/01/2003 | CN1122530C Vacines |
10/01/2003 | CN1122529C Biological diatetic health-care food containing metallic sulfure protein for diabetes and complication and preparation method |
09/30/2003 | US6627798 Nucleotide sequences coding polypeptide associated with tyrosine biosynthesis for use in generation of amplified tyrosine concentration in plants |
09/30/2003 | US6627769 Antiproliferative agents |
09/30/2003 | US6627754 Pyrrolo[2,3-d]pyrimidine compounds |
09/30/2003 | US6627746 DNA comprising nucleotide sequences that code for somatomedins and peptide domains |
09/30/2003 | US6627741 Isolated antibody or fragment thereof that specifically binds to a protein with a specified amino acid sequence, as well as a hybridoma encoding it |
09/30/2003 | US6627740 Monoclonol antibody which binds to a polypeptide having pre-B cell growth supporting ability |
09/30/2003 | US6627739 Antibodies having preferential binding to proteases; screening for enzyme inhibitors used in therapy of neurodegenerative diseases, such as Alzheimer's disease |
09/30/2003 | US6627738 No-modified hemoglobins and uses therefor |
09/30/2003 | US6627735 Islet cell antigen 1851 |
09/30/2003 | US6627733 Receptor tyrosine kinase with a discoidin-type binding domain |
09/30/2003 | US6627732 Enhanced hematopoiesis promoting effect |
09/30/2003 | US6627731 Thrombin derived polypeptides; compositions and methods for use |
09/30/2003 | US6627730 Of given amino acid sequence, and diagnostic test kit; multidrug resistance |
09/30/2003 | US6627729 TML peptides |
09/30/2003 | US6627625 Beta-lactam antibiotics and beta -lactamase inhibitors provides significant neurotropic effects in warm-blooded vertebrates evidenced inter by anxiolytic and antiaggressive behavior modification ans enhanced cognition |
09/30/2003 | US6627619 Cancer diagnosis |
09/30/2003 | US6627615 Methods and compositions for in vivo gene therapy |
09/30/2003 | US6627610 Treat a viral infection in a subject via inhibiting the prenylation of a protein contained in the virus infecting said subject, which method comprises administering to said subject an agent selected from the group consisting of amino |
09/30/2003 | US6627609 Peptides which contain N-methylated amino acid units and have improved water solubility. Medicaments in which the peptides according to the invention are contained can be used for the treatment of hormone- dependent tumours and |
09/30/2003 | US6627605 Polynucleotides which encode them, and methods for their use. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention further provides methods for diagnosing or treating disorders with |
09/30/2003 | US6627604 Memno peptides, process for their preparation and use thereof |
09/30/2003 | US6627602 Preventing desensitization of receptors |
09/30/2003 | US6627601 Amino acid sequences derived partially from ependymin that binds with calcium; stroke and other neurodegenerative diseases; antiischemic agents; cognition activators; conjugated to transfer through blood-brain barrier |
09/30/2003 | US6627440 Recombinant human alpha-fetoprotein as a cell proliferative agent |
09/30/2003 | US6627438 Nucleotide sequences for use in the generation of amidated peptides |
09/30/2003 | US6627425 Human glucose-6-phosphatase molecules and uses thereof |
09/30/2003 | US6627415 Isolated nucleic acid comprising a nucleotide sequence encoding fibrinogen-like domain; use in diagnosis and treatment of tumor angiogenesis, wound healing, thromboembolic diseases, atherosclerosis and inflammationinflammation |
09/30/2003 | US6627405 53BP2 complexes |
09/30/2003 | US6627403 Detecting hyperplasia in tissue sample; obtain tissue sample, isolate nucleotide sequence, detect chymotryptic nucleotide sequences, presence of sequences indicates hyperplasia |
09/30/2003 | US6627213 Administering on the same day the infant is fed human breast milk a supplement free of carbohydrate and comprising casein, salts of casein, whey, and casein hydrolysates; decrease of jaundice and increase of excretion of bilirubin |
09/30/2003 | US6627200 Utilization of CD 137 in order to promote the proliferation of peripheral monocytes |
09/30/2003 | US6627198 Therapy, prevention tuberculosis infections |
09/30/2003 | US6627197 Selective destruction of cells infected with human immunodeficiency virus |
09/30/2003 | US6627196 Dosages for treatment with anti-ErbB2 antibodies |
09/30/2003 | US6627195 Binding agents to CD23 |
09/30/2003 | US6627194 Activated immunoglobulin |
09/30/2003 | US6627193 Contacting medium with arginine-specific cysteine proteinase of bacterial origin to produce activated Protein C |
09/30/2003 | US6627189 Supressing expression of human p21 K-ras oncogene |
09/30/2003 | US6627187 Containing an amino acid as a stabilizer; long term storage stability |
09/30/2003 | US6627186 Treating neutrophil disorders; granulocyte colony stimulating factor (G-CSF) |
09/30/2003 | US6626982 Compound storage |
09/30/2003 | CA2262465C Neuritin, a neurogene |